Novo Nordisk A/S

Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment pro…

Biotechnology

DK, Bagsvaerd [HQ]

Financials

Analysts

Wall Street · Earnings · Institutional Sentiment

A comprehensive analysis section that covers unveiling insights about Novo Nordisk A/S's gradings, price targets and earnings estimates.

Earnings

See the historical earnings and what wall street analysts forecasted and
forecast for future earnings.

Reported

Past Estimate Consensus

Future Estimate Consensus

EPS Revenue EBITDA EBIT SGA

All monetary values are presented in USD ($). E stands for Estimate.
FY	EPS		Revenue [mil.]		Profit [mil.]		EBITDA [mil.]		EBIT [mil.]		Expenses · SGA [mil.]
		E		E		E		E		E		E
2015	-	6.627	-	107,255	-	29,785	-	51,002	-	46,940	-	30,620
2016	13.5600	7.766	107,927	115,075	34,860	263,811	52,488	54,721	49,444	50,362	32,169	32,852
2017	7.5000	7.923	111,780	114,363	37,925	235,536	51,616	54,383	48,432	50,051	32,339	32,649
2018	7.7100	8.050	111,696	111,597	38,130	239,563	52,164	53,067	48,967	48,840	32,124	31,859
2019	7.9800	8.045	111,831	118,180	38,628	249,843	51,164	56,198	47,248	51,721	33,313	33,739
2020	8.2000	8.837	122,021	125,101	38,951	252,296	57,791	59,489	52,483	54,750	35,830	35,714
2021	9.0300	10.304	126,946	139,787	42,138	292,366	60,215	66,472	54,126	61,178	36,886	39,907
2022	10.4000	12.162	140,800	175,684	47,757	343,865	67,556	83,543	58,644	76,888	41,058	50,156
2023	12.2600	18.111	176,954	226,803	55,525	370,752	82,040	107,851	74,809	99,261	50,684	64,749
2024	18.6700	22.752	232,261	286,513	83,683	102,266	112,940	136,245	102,574	125,393	61,598	81,796
2025	-	28.518	-	345,067	-	128,183	-	164,089	-	151,019	-	98,512
2026	-	34.393	-	403,696	-	2.F11X/td>	-	2.F111/td>	-	2.F111	-	2.F111
2027	-	38.437	-	443,284	-	1.F12X/td>	-	1.F121/td>	-	1.F121	-	1.F121
2028	-	43.307	-	501,163	-	0.F13X/td>	-	0.F131/td>	-	0.F131	-	0.F131

Institutional Sentiment

Wall Street · Earnings · Institutional Sentiment

The institutional sentiment measures the direction of new stock gradings
and price targets while comparing them Year-over-Year. We've limited the grading institutes to those we see as top-tier and update this data every month.

Morgan Stanley

1Y Ago:

Overweight

Prev. Grade

n/a

Nov. 6, 2024

Overweight

JP Morgan Chase

1Y Ago:

n/a

Prev. Grade

n/a

Latest

n/a

Citigroup

1Y Ago:

Underweight

Prev. Grade

Underweight

Nov. 6, 2024

Underweight

Overall Consensus

Here we aggregate the price targets and gradings of all IBs/AMCs/Brokerage firms inside our database to draw a bigger picture.

Grading Consensus

Click to each, to see the grade

Price Target Consensus

-35.932% $37.75 · MISS

Nov. 6, 2024

Price Then

$110.13

Price Target

$142.81

Price Now

$105.06